[Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Vigabatrin (VGB) is a new antiepileptic drug, that acts by the irreversible inhibition of gamma-aminobutyric acid (GABA) aminotransferase. Chronic antiepileptic therapy with VGB is associated with visual field defects and electrophysiological changes.
Mrugacz
Małgorzata
M
Kliniki Okulistyki Dzieciecej Akademii Medycznej w Białymstoku.
Bakunowicz-Łazarczyk
Alina
A
D000927:Anticonvulsants / Q000009:adverse effects*; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D020888:Vigabatrin / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced*; D014794:Visual Fields / Q000187:drug effects*
D000927:Anticonvulsants; D020888:Vigabatrin